Background: Dementia is associated with disruptions in sleep and sleep quality for patients and their family caregivers. Little is known about the impact of frontotemporal dementia (FTD) on sleep.
T he neurological deterioration associated with dementia contributes to disturbances in nighttime behavior and sleep. Disrupted nighttime sleep occurs in many types of dementia. In Alzheimer's disease (AD), such disruptions include insomnia, frequent nighttime awakenings, decreased total nighttime sleep, increased daytime sleep, and evening agitation (Dowling et al., 2005) . Nightime sleep disruption is even more common in dementia with Lewy bodies compared to AD. Patients with dementia with Lewy bodies experience more movement disorders during sleep and more daytime sleepiness (Bliwise et al., 2011) . Patients with vascular dementia experience disruption in sleep-wake cycles and decreased sleep efficiency (Aharon-Peretz et al., 1991) . Nighttime sleep disruption is difficult to treat, and pharmacological management is associated with negative side effects (McCurry & Ancoli-Israel, 2003) .
Much less is known about sleep in frontotemporal dementia (FTD) . FTD refers to a range of neurodegenerative disorders characterized by focal atrophy of the frontal and/or anterior temporal lobes of the brain, resulting in profound behavioral, cognitive, and emotional symptoms (Brun, 1987; Neary et al., 1998; Rosen et al., 2005) . Two subtypes of FTD include the behavioral variant (bvFTD) and semantic dementia (SD). Sleep disruption, characterized by increased nocturnal activity, decreased morning activity, and excessive daytime sleepiness have been reported, but not well characterized, in FTD (Anderson, Hatfield, Kipps, Hastings, & Hodges, 2009; Harper et al., 2001; Merrilees, Hubbard, Mastick, Miller, & Dowling, 2009) .
Sleep is an important issue for the family members who care for patients with dementia. Approximately two thirds of adult family caregivers complain of disrupted sleep (McCurry et al., 1999; Wilcox & King, 1999) . Dementia family caregivers sleep less and have poorer ratings of sleep quality compared to noncaregivers (McKibbin et al., 2005; von Känel et al., 2010) . Nighttime behaviors of patients with dementia are often associated with sleep problems in family caregivers (McCurry, Logsdon, Teri, & Vitiello, 2007) , and sleep disruption is a major reason why family members institutionalize their care recipients (Hope, Keene, Gedling, Fairburn, & Jacoby, 1998; Yaffe et al., 2002) . Poor sleep quality has been shown to contribute to depression and elevated biomarkers of increased atherosclerotic risk among family caregivers of persons with AD (Rowe, McCrae, Campbell, Benito, & Cheng, 2008; Simpson & Carter, 2013; von Känel et al., 2010) , and more research describing the nature of sleep disruptions and their impact on sleep quality in patients with FTD and their caregivers are needed. Caregivers of patients with FTD have not been the focus of sleep research, although a case of a spouse caregiver of a patient with bvFTD whose ratings of emotional distress for the patient's nighttime behavior increased during a 3-year period of caregiving was reported (Merrilees et al., 2009) . The purposes of this study were to characterize sleep (using actigraphy and subjective assessments) in patients with mild to moderate bvFTD and SD and their primary family caregivers and to compare patient and caregiver data.
METHODS

Participants
Subjects were recruited from an ongoing National Institutes of Health funded Program Project Grant examining FTD at the University of California, San Francisco Memory and Aging Center. To be included, patients needed to have a diagnosis of FTD, be living at home, and have a family caregiver willing to participate. Clinical diagnoses were established by consensus agreement of a panel of experts consisting of a neurologist, a neuropsychologist, and a clinical nurse specialist, applying the Neary criteria (Neary et al., 1998) . Consent for participation in this study was obtained according to approved institutional review board guidelines (including special protection for patients with cognitive impairment who rely on oversight by their surrogate). Twentytwo patient-caregiver dyads were enrolled: 13 bvFTD and 9 SD. All patients resided at home with their spouse caregivers.
Apparatus
Sleep and activity data were collected using MiniMitter Actiwatch monitors (AW-64). Developed in the early 1970s, actigraphy has become an accepted method for studying sleep patterns in patients with dementia Littner et al., 2003) . Actigraphy is movement-based monitoring used widely in sleep and circadian rhythm research based on the premise that activity is more prominent during wake periods and less prominent during sleep Morgenthaler et al., 2007) . Actiwatches are wristwatch-sized devices that use accelerometers to monitor the occurrence, degree, and speed of motion. A signal reflecting magnitude and duration of motion is generated, amplified, and digitized by an onboard circuit. This information is stored in memory as activity counts. The Actiwatches were programmed to collect data at 1-minute epochs continuously over the 2-week data collection period. Data were analyzed for bedtime (from "lights off" to "lights on") and the sleep interval that lies within the bedtime interval (the period between sleep start and sleep end). Percentage sleep, the ratio of time asleep to amount of time in bed, was used as a measure of sleep efficiency. Normal sleep efficiency in adults aged 55-60 years is 80.6% (SD = 11.7) and 79.2% (SD = 10.1) in adults 61 years and older (Bliwise, 2005) . Other sleep-related outcome variables included (a) length of time in bed (in hours), (b) sleep interval duration (minutes), (c) percent sleep (percentage of time asleep from sleep onset to final wake time), (d) total minutes awake within the sleep interval, (e) number of wake bouts within the sleep interval, and (f) wake bout duration (mean duration of wake bouts within the sleep interval in minutes).
Other Measures
Data collected on patients included demographics, dementia severity, cognitive performance, and behavioral symptoms. Caregiver data included demographics, sleep quality, and emotional distress related to the presence of nighttime disruption in the patient. Caregivers also maintained a "sleep diary" or record of sleep-wake times for both the patient and themselves that was used to aid in scoring the actigraphy data.
Dementia Severity
The Clinical Dementia Rating (CDR) was used to stage the severity of dementia (Morris, 1993) . Scores range from 0 (no dementia) to 3 (severe dementia). The CDR has good reliability and validity (Morris et al., 1997) . The Mini-Mental State Examination is a brief, 30-point scale with established reliability and validity as a measure of cognitive function (Folstein, Folstein, & McHugh, 1975) .
Neurobehavior The Neuropsychiatric Inventory, a structured interview with established reliability and validity, was used to assess 12 neurobehavioral domains in patients and the associated severity of caregiver's distress (Cummings et al., 1994) . The behavioral domains were delusions, hallucinations, agitation, depression, anxiety, euphoria, apathy, disinhibition, irritability, aberrant motor behavior, nighttime behavior, and eating/appetite. There was a "yes" or "no" screening question for each domain, and if the respondent answered affirmatively, additional questions were asked. For example, to assess nighttime behavior, the following screening questions were asked: "Does the patient have difficulty sleeping (do not count as present if the patient simply gets up once or twice per night only to go to the bathroom and falls back asleep immediately)?" "Is he/she up at night?" "Does he/she wander at night, get dressed, or disturb your sleep?" If the caregiver answered yes, then additional questions were asked regarding the presence of excessive daytime sleeping, early morning awakenings, and any other nighttime behaviors. The severity and frequency of each symptom was rated with higher scores indicating greater behavioral symptomatology. For the purposes of this study, only the domain for nighttime behavior was included. The nighttime behavior score was derived by multiplying the frequency and severity scores. In addition, the score reflecting the emotional distress experienced by the caregiver related to nighttime behavior (ranging from 0 [no distress] to 5 [very severely distressful] with higher scores indicative of greater emotional distress was included (Cummings, 1997) .
Caregiver Sleep Quality Characteristics of caregivers' sleep
during the last month were assessed using the Pittsburgh Sleep Quality Index (PSQI), a standardized quantitative measure of sleep quality developed to identify "good" and "poor" sleepers. A global PSQI score of greater than 5 indicates poor sleep quality and correlates well with clinical and/or laboratory measures (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989) . Daytime dysfunction was measured using Question 8: "During the past month, how much of a problem has it been for you to keep up enough enthusiasm to get things done?" Rating response options were 0 = no problem at all, 1 = very slight problem, 2 = somewhat of a problem, and 3 = a very big problem. Sleeping medication use was measured using Question 6: "During the past month, how often have you taken medicine to help you sleep (prescribed or over the counter)?" Response options were 0 = not during the past month, 1 = less than once a week, 2 = once or twice a week, and 3 = three or more times a week.
Procedure
After consenting to participate in the study, patients and their primary family caregivers were fitted with an Actiwatch and received verbal and written instructions. The Actiwatches were programmed to begin monitoring activity on the Monday afternoon after the research visit. Subjects were instructed to affix the Actiwatches to their nondominant wrist and to wear them at all times for the ensuing 2 weeks. In addition to written instructions, caregivers also received sleep diaries and the PSQI to complete at home. At the end of the 2-week data collection period, the watches, diaries, and questionnaires were returned to study staff in a self-addressed, prepaid mailer, and the data were downloaded and scored.
Statistical Analysis
Actigraphy records were analyzed for both patient and caregiver dyads on the medium sensitivity setting. Areas of validated "watch off" time were validated by reviewing diary reports and confirming these times in the actigraphs. In addition, all actigraphs were reviewed for any periods greater than 2 hours when there was no recorded activity, indicating the watch was most likely off the wrist. These "watch off" times were deleted from the analysis. Records for both members of each dyad were "matched" by deleting identical periods on both records to ensure accuracy in comparison. For example if the patient had removed the watch one night, the data for both patient and caregiver were excluded for that night. Seven of the 22 participants had data removed in this process, and the overall mean hours of data removed was 31.5 (SD = 61.6 hours). To facilitate visual comparison, the actogram activity scale was calibrated to be the same for both data sets. Raw actigraphy data were subjected to a scoring algorithm in the Actiware software. Bed and rise times were interpreted by the analyst based on diary entries and the raw data. Lights out/attempt to sleep was scored as the first epoch with at least a 200 count drop in activity over 3 minutes and sustained, and lights on/last wake in the morning was scored as the first epoch with at least a 200-count increase in activity over 3 minutes and sustained. Sleep was calculated by the software algorithm based on immobility where 10 continuous minutes of inactivity was categorized as sleep. Epochs were then scored as sleep, starting with the first minute of inactivity. The rules to determine sleep and wake parameters were based on the experience reviewing and scoring hundreds of actigraphy records for patients with neurodegenerative disorders (e.g., Parkinson's disease, Note. Bedtime and rise time were obtained from diary data. Other variables were derived from actigraph recordings. FTD = frontotemporal dementia; ATSI = awake time in sleep intervals. dementia). The rules took into account differences in mobility in these populations compared to the general population, for which the default scoring algorithms are calculated. SPSS software was used for additional data analyses. Nonparametric independent samples analyses were employed to compare patients with bvFTD to SD and bvFTD caregivers to SD caregivers. Paired samples were used to compare the bvFTD and SD patient groups with their respective caregiver groups.
RESULTS
Subject Characteristics
Patient and caregiver characteristics are summarized in Table 1 .
Of the 22 caregivers, 14 were women: 9 in the bvFTD group and 5 in the SD group. The mean Mini-Mental State Examination scores for bvFTD patients was 24.5 (SD = 3.8) compared to 16.4 (SD = 9.1) for patients with SD (p = .009). CDR scores were higher (indicating greater dementia severity) in patients with bvFTD compared to those with SD (M = 1.6, SD = 0.6; M = 1.0, SD = 0.6, respectively; p = .03).
Sleep
The Neuropsychiatric Inventory nighttime sleep disruption rating results are presented in Table 2 . Nighttime disruption was reported more often in patients with bvFTD than SD (85% vs. 33%). Descriptively, nighttime disruption was more often rated as occurring frequently or very frequently in patients with bvFTD compared to those with SD. There was a strong positive correlation between nighttime behaviors in patients with bvFTD and caregiver distress related to sleep disruption (rho = .67, p < .05), but not in the SD group. Actigraphy and diary data are presented in Table 3 . Wilcoxon sign-rank tests of time spent in bed for the patients and their caregivers revealed significant differences for the bvFTD dyads (Z = 2.06, p = .04) and the SD dyads (Z = 2.67, p = .004). Both bvFTD and SD patient groups spent significantly more time in bed than their caregivers. Although both patient groups showed a slightly higher percentage of sleep compared to their caregivers, all four groups had sleep efficiencies greater than 80%. There were no significant differences in duration of the sleep interval, number of wake bouts, or wake bout duration between the groups. An example of actigraphs for one patientcaregiver dyad is displayed in Figure 1 .
Caregiver Sleep Quality
Caregiver sleep quality data are presented in Table 1 . The average PSQI global score was 7.8 (SD = 4.2) for the bvFTD caregivers and 4.9 (SD = 2.5) for the SD caregivers, indicating poor sleep quality for the bvFTD caregivers and adequate quality for the SD caregivers, on average, based on the published cutpoint. Overall, female caregivers reported poorer sleep quality (higher PSQI scores) than male caregivers. In addition, 92% of bvFTD caregivers reported that they experienced daytime dysfunction during the past month by indicating that it had been a problem for them to keep up enough enthusiasm to get things done. Only 37% of SD caregivers reported this same problem. Female, but not male, caregivers reported using sleep medications. Fifty-four percent of the female bvFTD caregivers reported taking medicine for sleep, with 41% of these using sleep medication more than three times a week. Only one SD caregiver reported using sleep medication, and this was less than one time per week.
DISCUSSION
Caregiver reports show that patient nighttime disruption is an important feature of FTD. In this cohort of patients with CDR scores indicating mild disease severity, nighttime behaviors were reported in 85% of patients with bvFTD and correlated strongly with caregiver distress. The number of caregivers of patients with SD who reported any nighttime behaviors in the patient was too small to comment on the association between nightime behaviors and caregiver distress. The bvFTD caregivers were more likely to rate themselves as having poor sleep quality. The bvFTD caregivers were taking sleep medications three times a week or more. In addition, a higher percentage of bvFTD caregivers compared to SD reported trouble with daytime enthusiasm. Yet, despite these subjective ratings of poor sleep quality, actigraphy data demonstrate sleep efficiencies considered to be within the normal range. These data suggest that caregiver complaints about sleep could be influenced by factors other than sleep disruption in the patient. Subjective reports of sleep disruption do not always correlate with objective measures of sleep (Hoekert, der Lek, Swaab, Kaufer, & Van Someren, 2006; McCurry, Vitiello, Gibbons, Logsdon, & Teri, 2006) . For example, in a study comparing subjective ratings with objective measures of sleep efficiency, the presence of depression, lower levels of social support, being overcommitted at work, and being less happy were factors associated with poorer self-ratings of sleep efficiency despite objective measures indicating normal sleep efficiency (Jackowska, Dockray, Hendrickx, & Steptoe, 2011) . In another study comparing female caregivers to noncaregivers, caregivers rated their sleep quality as poorer despite similar sleep patterns in both groups (Castro et al., 2009) . In the author's experience, caregivers report that worry and anxiety about the patient (e.g., vigilience about safety) and other issues (e.g., financial, legal, and healthcare-related decisions) prevent them from sleeping soundly. This study did not explore these factors.
Results regarding poor sleep quality are important in considering the potential negative consequences that caregiving has on health. Disrupted sleep has been associated with medical and psychiatric illnesses such as depression, anxiety, cognitive dysfunction, and reduction in quality of life (Neikrug & Ancoli-Israel, 2010) . Poor sleep is also associated with negative health outcomes in reaction times, functional performance (Koslowsky & Babkoff, 1992) , and excessive daytime sleepiness (Neikrug & Ancoli-Israel, 2010) . People experiencing poor sleep often use sleep medicines, alcohol, and daytime caffeine as strategies for managing sleep disruption. Nurses play a critical role as advocates for the health and well-being of dementia family caregivers. Caregivers typically ignore their own health because of the time and burden of providing care to the person with dementia, thus compounding the risks to their own physical and emotional well-being. Results from this study reinforce the need to attend to subjective complaints about sleep and sleep quality. Nurses are in a position to assess for sleep disruption among caregivers and to promote strategies that promote good sleep.
Results from this study underscore the necessity of using both quantitative/objective measures of sleep and behavior and subjective ratings. Although caregiver reports are valuable, such ratings may be biased and influenced by caregiver fatigue and burden (McCurry, Gibbons, Logsdon, & Teri, 2004) . Community-based monitoring is valuable because it facilitates research in patients with earlier, milder stages of disease and allows maximum freedom for the subjects to engage in their typical activity. Monitoring in laboratory or institutional settings can create problems with data being confounded by institutional variables (e.g., lack of outdoor light, imposed bedtime; Ancoli-Israel, Clopton, Klauber, Fell, & Mason, 1997; Ancoli-Israel, Klauber, et al., 1997) .
Limitations
There are limitations to this study. The inclusion of actigraphy data from age-matched normal controls would enhance knowledge of the potential differences between patients, caregivers, and noncaregivers. Although nighttime disruption was endorsed, it is not clear whether the disruption was because of nighttime awakenings, trouble falling or staying asleep, or other types of disturbances. It may be that certain disruptions are more stressful than others, but this was not assessed in this study. Also, a potential limitation of the PSQI is that subjects are asked to rate sleep items over the past month, which likely does not capture day-to-day variability, nor does it match the 2-week actigraphy data collection. The presence of primary sleep disorders (e.g., sleep apnea, rapid eye movement sleepbehavior disorder, periodic limb movements of sleep) were not assessed in either the patients or caregivers, caregiver depression, or other factors that could influence sleep and sleep quality or patient's use of medicines that could affect sleep. Data on whether patients and caregivers shared the same bedrooma factor that could influence aspects relating to sleep and sleep quality-were also not collected.
Conclusions
Although nighttime disturbances are reported by caregivers of patients with bvFTD and SD and associated with caregiver distress, objective measures of sleep efficiency and the timing of the sleep period appeared relatively normal. The caregivers of patients with bvFTD reported worse sleep quality compared to SD caregivers. The clinical manifestations of bvFTD produce different and more distressing impacts on the caregiver. These cohort differences suggest separate analysis of FTD subtypes is warranted and could provide data to inform interventions to minimize negative health outcomes for family caregivers and improve dementia care. Objective measurement of features of sleep in patients and their family caregivers holds promise as a method for accurately assessing sleep and sleep quality.
